Eltrombopag in pediatric chronic and refractory ITP: data from a retrospective multicenter study from Lebanon
Autor: | Peter, Noun, Adlette, Inati, Rana, Raffoul, Jennifer Abi, Younes, Joelle, Mardini, Hassan, Khalife |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Annals of Hematology. 101:991-997 |
ISSN: | 1432-0584 0939-5555 |
DOI: | 10.1007/s00277-022-04804-z |
Popis: | About 20% to 30% of pediatric patients with immune thrombocytopenia (ITP) develop chronic or refractory disease lasting 12 months or more that can be challenging to treat. Eltrombopag is being used after failure of previous lines of therapy with good results at tertiary healthcare centers in Lebanon, a developing country with available multidisciplinary treatment modalities. This is a retrospective multicenter observational study that analyzed data on pediatric patients with chronic or refractory ITP who were given eltrombopag as second- or third-line therapy in 6 large referral hospitals in Beirut (country capital located in mid Lebanon), South, North, and Mount Lebanon between October 2016 and May 2020. The primary end point of the study was a proportion of patients achieving platelet counts of ≥ 50 × 10 |
Databáze: | OpenAIRE |
Externí odkaz: |